Adjuvant Chemo Should Be Used in Gynecologic Carcinosarcoma Adjuvant Chemo Should Be Used in Gynecologic Carcinosarcoma
Patients with gynecologic carcinosarcoma benefit from adjuvant chemotherapy following surgery, even if they have early-stage disease, indicates a"very important '" analysis of registry data.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 20, 2022 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
NRG Oncology trial sets new standard regimen for women with uterine carcinosarcomas
(NRG Oncology) Results from the phase III NRG Oncology clinical trial GOG 0261 comparing paclitaxel plus carboplatin (PC) to paclitaxel plus ifosfamide (PI) in women with stage I-IV, recurrent carcinosarcoma of the uterus or ovary, indicate that the PC combination treatment should be considered a standard of care for this patient population. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 3, 2019 Category: Cancer & Oncology Source Type: news
Genetic analysis better explains how uterine cancers resist treatment
Researchers have charted the complex molecular biology of uterine carcinosarcoma, a rare and aggressive gynecologic cancer, according to a new study. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 13, 2017 Category: Science Source Type: news
Genetic analysis better explains how uterine cancers resist treatment
(NYU Langone Medical Center / New York University School of Medicine) Researchers have charted the complex molecular biology of uterine carcinosarcoma, a rare and aggressive gynecologic cancer, according to a study published on March 13 in Cancer Cell. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 13, 2017 Category: Cancer & Oncology Source Type: news
Cancer spreading: Caught in the act
Scientists at the California NanoSystems Institute at UCLA have taken a major step toward confirming an unusual theory of how some cancer cells metastasize. Their findings may lead to new strategies for keeping melanoma from spreading.
A commonly held theory about how cancer spreads is that tumor cells break off from the primary tumor and travel through the bloodstream to reach other organs, where they attach and grow into new tumors. But questions about that process have remained because circulating tumor cells in the blood sometimes have a short lifespan, and because of a lack of knowledge about how the cells leave the...
Source: UCLA Newsroom: Health Sciences - August 15, 2016 Category: Universities & Medical Training Source Type: news
Genetics of Uterine Carcinosarcoma: Case & Cohort Analysis Genetics of Uterine Carcinosarcoma: Case & Cohort Analysis
Mutational analysis is providing answers to the many questions associated with uterine carcinosarcoma. Are targeted therapies ahead for this rare malignancy?Cancer Control: Journal of the Moffitt Cancer Center (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 2, 2016 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
